The remarkable improvement in the survival of surgically and interventionally treated patients with congenital heart disease (CHD) has led to an increasing number of adults with this condition, in particular those with more complex disease. In addition, there are CHD lesions newly diagnosed during adult life such as atrial septal defect, coarctation of the aorta, Ebstein's anomaly, and congenitally corrected transposition of the great arteries. The 32 nd Bethesda Conference report in 2001 1 estimated that there were 2800 adults with CHD/million population, with more than half having moderately or highly complex disease. A later study 2 reported a prevalence of even 4090/million adults in Quebec for the year 2000. In Europe, the population of grown-ups with congenital heart disease (GUCH) was estimated at around 2.3 million in 2010, already outnumbering the paediatric CHD population of 1.9 million patients. 3 There is expert consensus that GUCH patients have very special needs and that physicians responsible for their care therefore need specific expertise and training. [4] [5] [6] Although the majority of GUCH patients will have had successful surgical or catheter interventional treatment during childhood, most cannot be considered cured but require long-term surveillance and often re-interventions over their lifetime for residual anatomical and/or functional abnormalities in order to maintain the success of primary treatment. The wide variety of congenital defects and their specific long-term problems as well as changing treatment strategies including medical, device, surgical, and interventional techniques remains a particular challenge when seeking to provide optimal long-term care. [4] [5] [6] Specific recommendations for the organization of care and training programmes for those involved in the care of this special population have therefore been published over the years. 5, 6 Originally, guidelines 7 had stratified patient care into three levels by CHD diagnosis: (i) patients who require care exclusively followed-up in a specialist centre (level 3); (ii) patients in whom shared care can be established with the appropriate general adult cardiac services (level 2); and (iii) patients who can be managed in 'nonspecialist' clinics (with access to specialist care if required; level 1). The current ESC guidelines, 4, 6 however, no longer attempted to assign a hierarchy of care based on the underlying CHD lesion because it was recognized that complex defects can easily be assigned to level 2 and 3, but even simple defects may require specialist care under certain circumstances (e.g. atrial septal defect with pulmonary arterial hypertension). It was therefore felt that the best model of care is one in which GUCH patients are seen at least once in a specialist centre and the GUCH specialist should then make recommendations for the level of care and follow-up intervals on an individual patient basis. In any case, a functioning network between specialist centres, local general adult cardiology departments, cardiologists in private practice (where available), and family practitioners appears of critical importance. [4] [5] [6] The requirements of such specialist GUCH centres which should serve as centres of excellence that provide care on the highest level but also education and training for subspecialization in GUCH, while promoting research and innovation, have been defined by European and North American Cardiology Societies. [4] [5] [6] Such centres are recommended to serve a population of 5-10 million people. Cardiologists and primary care physicians who take care of GUCH patients should establish a referral relationship with a specialist centre. This should include the provision of timely telephone advice, informal consults, rapid consultant review, as well as shared care arrangements for patient follow-up. These recommendations for GUCH care are to a large degree expert consensus, and few data are available providing evidence that such specialized care does improve the outcome of adult CHD (ACHD) patients. Cordina and colleagues provide important new data in this regard in the current issue of the journal. 8 They analysed referral sources and appropriateness of management for patients referred to their tertiary ACHD centre over the past 3 years. Almost half of the patients were referred from general cardiologists and only one-third from cardiologists with a dedicated speciality training in CHD. The remaining patients were referred from other medical teams coming across their CHD by chance when seen for other medical problems. The key finding of the study is that non-adherence to current treatment guidelines was common, with 37% of patients in those referred from non-specialized cardiologists. Such management errors resulted in catastrophic or major consequences in 37% of these patients and were moderately important in 35% (minor deviations from guidelines in 28%). In contrast, management errors were rare among referrals from CHD-specialized cardiologists (10%), with catastrophic consequences in none, major consequences in 2%, and moderate consequences in 2% of the referred patients. Based on their data, they calculated that care at a specialized ACHD centre rather than by non-specialist cardiologists could avoid 400 adverse events for every 2000 patients transferred to adult care. Differences in management errors were highly significant not only in patients with highly and moderately complex but also in those with simple defects. This supports the guideline recommendation that all CHD patients regardless of disease complexity should ideally be seen at least once in a specialized centre. 6 A major limitation of this study is selection bias. The study only includes patients who eventually were referred to a specialized centre. It remains open how many are not referred at all, how frequent management errors occur in these, and what the consequences are. In any case, however, the data strongly support that non-specialized care of ACHD frequently results in management errors with a considerable rate of serious consequences that must have a strong negative impact on the long-term outcome. This has indeed been confirmed by another study that used a completely different approach. Mylotte et al. 9 took advantage of the Canadian healthcare system that records information of all residents which allows for the reconstruction of an individual's medical history in terms of diagnoses, hospitalizations, and medical services received. Overall, they observed a significant increase in referral rates to specialized ACHD centres over the years, which was followed in parallel by a significant reduction in expected ACHD patient mortality. More importantly, in exploratory post-hoc cohort and case-control analyses, specialized ACHD care was independently associated with reduced mortality and a reduced odds of death, respectively. After adjustment for patient characteristics, the hazard of death was 22% lower in patients whose first visit was to a specialized ACHD centre in comparison with those whose first visit was to a non-referral Take home figure Impact of specialized adult care on congenital heart disease outcome. Left upper panel: non-adherence to current guidelines was common in patients referred by non-specialized cardiologists with catastrophic, major, or moderate consequences in 26% but rare in patients referred by congenital heart disease cardiologists (major or moderate consequences in 4%). 8 Right upper panel: patients followed in a specialized referral centre had a significantly better survival compared with those treated in non-specialized centres in Canada. centre. The key findings of both studies are summarized in Take home figure together with a typical example of a management error under non-specialized care frequently observed by Cordina et al. 8 The message that non-specialized care has a markedly negative impact on the outcome of ACHD becomes even more alarming when taking into account how many patients must currently be assumed not to receive adequate care in referral centres. Canada has been a pioneering country with regard to ACHD care. Guidelines to this effect were presented as early as 1996. The healthcare system in Canada with its central organization and universal health insurance is particularly well suited to establish the recommended medical care nationwide. Nevertheless, two decades later, less than a third of eligible patients actively receive specialized ACHD care. 10 In the USA, this proportion is expected to be even significantly less. 11 In
Europe, Germany is a country where attempts to improve the quality of GUCH care were also made early on, presenting recommendations for physician training and organization of care. A certification process for both the subspecialty GUCH as well as super-regional specialized GUCH centres was established years ago. By December 2016, 16 super-regional centres and 300 cardiologists/paediatric cardiologists had been certified for a population of 80 million, but experts estimate that more than two-thirds of GUCH patients still do not receive specialized care.
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There are several reasons why patients may not receive specialized ACHD care. A preliminary analysis of a survey in Germany found out that 41% of GUCH patients and 38% of primary care physicians still did not know about specialized centres. 13 Only 18% of the latter involved a GUCH specialist in their treatment decisions for this patient group. It is well known that appropriate transition from paediatric to adult cardiology is crucial to minimize loss of patients and guarantee specialized ACHD care. However, well-organized transition programmes are frequently missing and, even in the most experienced CHD centres, transition to ACHD care has been reported to fail in up to 50%. 14 This is due not only to inadequately designed transition programmes but also to patient-related factors such as 'adolescent rebellion', the patient's desire to be 'normal', or financial constraints, particularly in countries without universal health insurance. 14 Financial constraints occur on the healthcare provider side, too. In Europe, reimbursement is frequently inadequate, particularly for outpatient care of this resource-demanding patient group. Finally, there are still not enough specialized GUCH centres and GUCH training programmes.
In conclusion, ACHD care is still frequently in non-specialized hands, resulting in high rates of management errors and adverse events, as well as increased mortality. Inadequate ACHD care indeed threatens the currently good results of CHD care during childhood. The care in specialized ACHD centres can significantly improve the outcome of this patient group. Major efforts are still required to facilitate specialized care for all ACHD patients including education of patients, education and training of physicians, as well as education of health service providers and healthcare politicians.
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